Nonsteroidal Anti-Inflammatory Drugs for Retinal Disease
Nonsteroidal anti-inflammatory drugs (NSAIDs) are used extensively in ophthalmology for pain and photophobia after photorefractive surgery and to reduce miosis, inflammation, and cystoid macular edema following cataract surgery. In recent years, the US Food and Drug Administration has approved new t...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2013-01-01
|
| Series: | International Journal of Inflammation |
| Online Access: | http://dx.doi.org/10.1155/2013/281981 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832556913149083648 |
|---|---|
| author | Scott D. Schoenberger Stephen J. Kim |
| author_facet | Scott D. Schoenberger Stephen J. Kim |
| author_sort | Scott D. Schoenberger |
| collection | DOAJ |
| description | Nonsteroidal anti-inflammatory drugs (NSAIDs) are used extensively in ophthalmology for pain and photophobia after photorefractive surgery and to reduce miosis, inflammation, and cystoid macular edema following cataract surgery. In recent years, the US Food and Drug Administration has approved new topical NSAIDs and previously approved NSAIDs have been reformulated. These changes may allow for greater drug penetration into the retina and thereby offer additional therapeutic advantages. For example, therapeutic effects on diabetic retinopathy and age-related macular degeneration may now be achievable. We provide an updated review on the scientific rationale and clinical use of NSAIDs for retinal disease. |
| format | Article |
| id | doaj-art-bd4a72b4a8c142e799401bea9639933b |
| institution | Kabale University |
| issn | 2090-8040 2042-0099 |
| language | English |
| publishDate | 2013-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | International Journal of Inflammation |
| spelling | doaj-art-bd4a72b4a8c142e799401bea9639933b2025-02-03T05:44:06ZengWileyInternational Journal of Inflammation2090-80402042-00992013-01-01201310.1155/2013/281981281981Nonsteroidal Anti-Inflammatory Drugs for Retinal DiseaseScott D. Schoenberger0Stephen J. Kim1Vanderbilt Eye Institute, Vanderbilt University Medical Center, Nashville, TN 37232, USAVanderbilt Eye Institute, Vanderbilt University Medical Center, Nashville, TN 37232, USANonsteroidal anti-inflammatory drugs (NSAIDs) are used extensively in ophthalmology for pain and photophobia after photorefractive surgery and to reduce miosis, inflammation, and cystoid macular edema following cataract surgery. In recent years, the US Food and Drug Administration has approved new topical NSAIDs and previously approved NSAIDs have been reformulated. These changes may allow for greater drug penetration into the retina and thereby offer additional therapeutic advantages. For example, therapeutic effects on diabetic retinopathy and age-related macular degeneration may now be achievable. We provide an updated review on the scientific rationale and clinical use of NSAIDs for retinal disease.http://dx.doi.org/10.1155/2013/281981 |
| spellingShingle | Scott D. Schoenberger Stephen J. Kim Nonsteroidal Anti-Inflammatory Drugs for Retinal Disease International Journal of Inflammation |
| title | Nonsteroidal Anti-Inflammatory Drugs for Retinal Disease |
| title_full | Nonsteroidal Anti-Inflammatory Drugs for Retinal Disease |
| title_fullStr | Nonsteroidal Anti-Inflammatory Drugs for Retinal Disease |
| title_full_unstemmed | Nonsteroidal Anti-Inflammatory Drugs for Retinal Disease |
| title_short | Nonsteroidal Anti-Inflammatory Drugs for Retinal Disease |
| title_sort | nonsteroidal anti inflammatory drugs for retinal disease |
| url | http://dx.doi.org/10.1155/2013/281981 |
| work_keys_str_mv | AT scottdschoenberger nonsteroidalantiinflammatorydrugsforretinaldisease AT stephenjkim nonsteroidalantiinflammatorydrugsforretinaldisease |